Back to search

Pherosyn Ltd

12434594

active
ltd
england wales
Companies House
Health Score
85 / 100

Healthy

25/30
Filing
20/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)

Details

Rothamsted Research, West Common, Harpenden, AL5 2JQ
Incorporated 30/01/2020

Compliance

Last accounts

28/02/2025

micro entity

Next accounts due

30/11/2026

On track

Confirmation statement

Last: 29/01/2026

Due 12/02/2027

On track

Industry

20200
Manufacture of pesticides and other agrochemical products

Officers

Daniel Ryan Bahia

director · Since 30/01/2020

British · England

Michael Alexander Birkett

director · Since 30/01/2020

British · United Kingdom

Mr Daniel Ryan Bahia

director · Since 30/01/2020

CHEMIST

BRITISH · ENGLAND

Dr Michael Alexander Birkett

director · Since 30/01/2020

CHEMIST

BRITISH · UNITED KINGDOM

Dr Mary Louise Ellis

director · Since 16/05/2023

CONSULTANT

BRITISH,CANADIAN · ENGLAND

Mary Louise Ellis

director · Since 16/05/2023

British,Canadian · England

David Kenneth Lawrence

director · Since 23/01/2024

British · United Kingdom

Dr David Kenneth Lawrence

director · Since 23/01/2024

COMPANY DIRECTOR

BRITISH · UNITED KINGDOM

Also on 7 other boards

Tina Elizabeth Lawton

director · Since 01/05/2024

British · Switzerland

Tina Elizabeth Lawton

director · Since 01/05/2024

COMPANY DIRECTOR

BRITISH · SWITZERLAND

Former

David Matthew Withall

director · Resigned 23/01/2024

John Christopher Caulfield

director · Resigned 23/01/2024

Bianca Forte

director · Resigned 26/02/2025

Persons with Significant Control

Dr Mary Louise Ellis

25–50% shares
25–50% votes

British,Canadian · England

Notified 17/12/2025

Mr Daniel Ryan Bahia

25–50% shares
25–50% votes

British · England

Notified 17/12/2025

Former PSCs

Dr Mary Louise Ellis

Ceased 07/06/2024

Change History

status → active
2026-07-17

Active

type → ltd
2026-07-17

Private Limited Company

address line1 → Rothamsted Research
2026-07-17

ROTHAMSTED RESEARCH

post town → Harpenden
2026-07-17

HARPENDEN

CompanyRankvs 21+ SIC 20200 peers
76

Financial strength78th percentile among SIC peers · 20/25
Employees92th percentile among SIC peers · 14/15
LiquidityCurrent ratio 35.15× · 20/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength20/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 28/02/2025

Net Worth

£728k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

£678k

Working capital

Current Assets

£698k

Current Liabilities

£20k

Fixed Assets

£50k

5avg. employees

Balance Sheet

Assets less current liabilities£728k
Prepared with Companies House

EstimatesDerived

YearCurrent RatioImplied Profit
202535.15+£0
202535.15+£306k
202423.04+£286k
20231.07—

Derived from filed accounts. Not audited figures.